Mirum Pharmaceuticals, Inc

(NASDAQ:MIRM)

Latest On Mirum Pharmaceuticals, Inc (MIRM):

Date/Time Type Description Signal Details
2023-05-07 08:03 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q1 2023 Earnings Call TranscriptN/A
2023-05-05 03:10 ESTNewsMirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81MN/A
2023-05-04 01:50 ESTNewsMirum Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-30 09:44 ESTNewsMirum Pharmaceuticals: Staying The CourseN/A
2023-04-13 08:06 ESTNewsMirum Pharmaceuticals prices notes worth $275MN/A
2023-04-12 19:36 ESTNewsMirum Pharmaceuticals reports preliminary unaudited financial results for Q1 2023N/A
2023-03-09 03:57 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q4 2022 Earnings Call TranscriptN/A
2023-02-14 11:04 ESTNewsMirum files for expanded approval of Livmarli in USN/A
2023-02-01 18:54 ESTNewsMirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo PharmaN/A
2022-11-29 09:10 ESTNewsMirum drops plans to develop liver disease candidate in pregnancyN/A
2022-11-20 19:55 ESTNewsMirum: Potential For European Approval To Move It ForwardN/A
2022-11-10 02:53 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 08:41 ESTNewsMirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03MN/A
2022-10-25 00:08 ESTNewsMirum says liver disease therapy met main goal in late-stage studyN/A
2022-10-14 19:50 ESTNewsMirum's liver disease drug Livmarli gets EMA committee nod for approval in EUN/A
2022-08-17 21:12 ESTNewsMirum: Great Sales Start For Livmarli Paves The Way For Long-Term GrowthN/A
2022-08-10 20:11 ESTNewsMirum Pharmaceuticals stock falls prices $80.0M stock offeringN/A
2022-08-10 02:57 ESTNewsMirum Pharmaceuticals falls aftermarket on $80M stock offeringN/A
2022-08-08 04:34 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 05:13 ESTNewsMirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08MN/A
2022-08-03 23:16 ESTNewsMirum Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-05-27 23:11 ESTNewsMirum Pharmaceuticals: Post-Approval Execution Looks ExcellentN/A
2022-05-24 00:37 ESTNewsMirum acquires San Diego-based Satiogen in stock and cash combinationN/A
2022-05-08 01:25 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 04:44 ESTNewsMirum Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 05:07 ESTNewsMirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43MN/A
2022-03-10 02:23 ESTNewsMirum Pharmaceuticals reports Q4 resultsN/A
2022-03-10 02:23 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 09:31 ESTNewsMirum Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-12 01:19 ESTNewsMirum Pharmaceuticals grants stock options under inducement planN/A
2021-12-17 06:35 ESTNewsMirum Pharmaceuticals Gets The 'Thumbs Up'N/A
2021-12-15 14:30 ESTNewsMirum Pharmaceuticals to join NASDAQ Biotechnology IndexN/A
2021-11-17 21:27 ESTNewsMirum Pharmaceuticals to sell Rare Pediatric Disease PRV for $110MN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals reports Q3 resultsN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 04:18 ESTNewsMirum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-12 04:54 ESTNewsMirum Pharmaceuticals: Livmarli Approval Could Spark A Bull Run For This Young BiotechN/A
2021-10-27 22:00 ESTNewsWarning: MIRM is at high risk of performing badlyN/A
2021-09-29 19:13 ESTNewsFDA approves Mirum Pharmaceuticals' Alagille syndrome treatment LivmarliN/A
2021-09-22 00:37 ESTNewsMirum Pharmaceuticals (MIRM) Investor Presentation - SlideshowN/A
2021-09-22 00:24 ESTNewsMirum submits application to EMA for maralixibat in Alagille SyndromeN/A
2021-09-22 00:12 ESTNewsMirum and Takeda ink exclusive licensing agreement to commercialize maralixibat in JapanN/A
2021-08-25 00:56 ESTNewsMirum And Maralixibat In Pediatric Cholestasis: The DifferentiationN/A
2021-08-08 15:26 ESTNewsMirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 06:42 ESTNewsMirum Pharmaceuticals beats on revenueN/A
2021-07-27 13:01 ESTNewsMirum Pharma inks maralixibat development deal for rare liver disease in South KoreaN/A
2021-07-21 15:36 ESTNewsMirum Is Undervalued Despite Expected Tough CompetitionN/A
2021-07-21 15:35 ESTNewsMirum Pharmaceuticals highlights maralixibat liver disease data analysesN/A
2021-07-21 15:34 ESTNewsMirum adds veteran biotechnology executive Carol Brosgart to board of directorsN/A
2021-07-21 15:27 ESTNewsAnalysis shows safety of Mirum's maralixibat for liver disorder maintained over five yearsN/A

About Mirum Pharmaceuticals, Inc (MIRM):

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.

See Advanced Chart

General

  • Name Mirum Pharmaceuticals, Inc
  • Symbol MIRM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 68
  • Fiscal Year EndDecember
  • IPO Date2019-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.mirumpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.53
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.56
  • Next Year EPS Estimate -$2.39
  • Next Quarter EPS Estimate -$0.64
  • Return on Assets -34%
  • Return on Equity -68%
  • Earnings Per Share -$28.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 610.52 million
  • PE Ratio -18.84
  • Analyst Target Price $50.29
  • Book Value Per Share $6.48
View More

Share Statistics

  • Shares Outstanding 30.42 million
  • Shares Float 12.19 million
  • % Held by Insiders 909%
  • % Held by Institutions 70.89%
  • Shares Short 674051
  • Shares Short Prior Month 637658
  • Short Ratio 5.61
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $27.43
  • 52 Week Low $10.14
  • 50 Day Moving Average 19.23
  • 200 Day Moving Average 19.6
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Mirum Pharmaceuticals, Inc (MIRM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Mirum Pharmaceuticals, Inc (MIRM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$1.43-$0.98-45.49%
2020-09-302020-11-12$N/A-$0.86-$0.9812.46%
2020-06-302020-08-06$N/A-$0.93-$0.87-6.5%
2020-03-312020-05-07$N/A-$0.86-$0.84-2.83%
2019-12-312020-03-12$N/A-$0.79-$0.856.73%
2019-09-302019-11-06$N/A-$0.84-$0.63-34.14%
2019-06-302019-08-28$N/A-$0.59-$0.590.47%

Mirum Pharmaceuticals, Inc (MIRM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Mirum Pharmaceuticals, Inc (MIRM) Chart:

Mirum Pharmaceuticals, Inc (MIRM) News:

Below you will find a list of latest news for Mirum Pharmaceuticals, Inc (MIRM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Mirum Pharmaceuticals, Inc (MIRM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-15500CALL0 0120.89TRUE00
2026-05-15550CALL0 0116.53TRUE00
2026-05-15600CALL0 0102.43TRUE00
2026-05-15650CALL0 0102.12TRUE00
2026-05-15700CALL0 091.07TRUE00
2026-05-15750CALL0 085.97TRUE00
2026-05-158020.4CALL0 187.07TRUE00
2026-05-15850CALL0 085.35TRUE00
2026-05-15900CALL0 2683.59TRUE00
2026-05-159510.4CALL0 100285.33TRUE00
2026-05-151000CALL0 579.21FALSE00
2026-05-151056.58CALL0 382.31FALSE00
2026-05-151100CALL0 45583.85FALSE00
2026-05-151150CALL0 082.51FALSE00
2026-05-151200CALL0 085.02FALSE00
2026-05-151250CALL0 3694.11FALSE00
2026-05-151303CALL0 889.8FALSE00
2026-05-151350CALL0 0110.4FALSE00
2026-05-151400CALL0 293.52FALSE00
2026-05-15500PUT0 0203.52FALSE00
2026-05-15550PUT0 0179.51FALSE00
2026-05-15600PUT0 0157.5FALSE00
2026-05-15650PUT0 0137.09FALSE00
2026-05-15700PUT0 0117.91FALSE00
2026-05-15750PUT0 0103.52FALSE00
2026-05-15803.32PUT579 101493.79FALSE0.920.38
2026-05-15855.7PUT0 686.16FALSE00
2026-05-15906.77PUT582 105291.37FALSE0.570.09
2026-05-15950PUT0 381.25FALSE00
2026-05-151000PUT0 080.35TRUE00
2026-05-151050PUT0 081.15TRUE00
2026-05-151100PUT0 081.33TRUE00
2026-05-151150PUT0 082.02TRUE00
2026-05-151200PUT0 082.17TRUE00
2026-05-151250PUT0 084.64TRUE00
2026-05-151300PUT0 082.28TRUE00
2026-05-151350PUT0 087.38TRUE00
2026-05-151400PUT0 083.92TRUE00
2026-06-18500CALL0 094.63TRUE00
2026-06-18550CALL0 095.28TRUE00
2026-06-18600CALL0 091.9TRUE00
2026-06-18650CALL0 089.36TRUE00
2026-06-18700CALL0 088.05TRUE00
2026-06-18750CALL0 086.68TRUE00
2026-06-18800CALL0 085.94TRUE00
2026-06-18850CALL0 083.34TRUE00
2026-06-18900CALL0 080.98TRUE00
2026-06-18950CALL0 080.33TRUE00
2026-06-1810011.75CALL579 101583.45FALSE-0.75-0.06
2026-06-1810510.1CALL0 982.87FALSE00
2026-06-181100CALL0 080.99FALSE00
2026-06-181150CALL0 080.8FALSE00
2026-06-181200CALL0 080.58FALSE00
2026-06-181250CALL0 083.32FALSE00
2026-06-181300CALL0 083.04FALSE00
2026-06-181350CALL0 084.62FALSE00
2026-06-181400CALL0 085.43FALSE00
2026-06-18500PUT0 0138.62FALSE00
2026-06-18550PUT0 0122.33FALSE00
2026-06-18600PUT0 0107.4FALSE00
2026-06-18650PUT0 093.56FALSE00
2026-06-18700PUT0 089.61FALSE00
2026-06-18750PUT0 088.02FALSE00
2026-06-18800PUT0 085.5FALSE00
2026-06-18850PUT0 082.04FALSE00
2026-06-18900PUT0 080.27FALSE00
2026-06-18950PUT0 081.39FALSE00
2026-06-181000PUT0 079.88TRUE00
2026-06-1810518.2PUT0 480.34TRUE00
2026-06-181100PUT0 079.78TRUE00
2026-06-181150PUT0 079.28TRUE00
2026-06-181200PUT0 079.39TRUE00
2026-06-181250PUT0 081.95TRUE00
2026-06-181300PUT0 081.99TRUE00
2026-06-181350PUT0 082.2TRUE00
2026-06-181400PUT0 082.29TRUE00
2026-07-17350CALL0 2105.71TRUE00
2026-07-17400CALL0 0101.61TRUE00
2026-07-17450CALL0 094.19TRUE00
2026-07-17500CALL0 088.86TRUE00
2026-07-17550CALL0 086.11TRUE00
2026-07-17600CALL0 084.24TRUE00
2026-07-17650CALL0 281TRUE00
2026-07-177028.6CALL5 163.56TRUE28.60
2026-07-17750CALL0 075.51TRUE00
2026-07-17800CALL0 2074.45TRUE00
2026-07-17850CALL0 072.62TRUE00
2026-07-17900CALL0 172.13TRUE00
2026-07-17950CALL0 071.41TRUE00
2026-07-171000CALL0 5071.85FALSE00
2026-07-171050CALL0 070.64FALSE00
2026-07-171100CALL0 171.03FALSE00
2026-07-171150CALL0 270.53FALSE00
2026-07-171200CALL0 2272.01FALSE00
2026-07-171250CALL0 272.03FALSE00
2026-07-171300CALL0 073.34FALSE00
2026-07-171350CALL0 172.43FALSE00
2026-07-171400CALL0 074.05FALSE00
2026-07-171450CALL0 074.4FALSE00
2026-07-171500CALL0 573.9FALSE00
2026-07-171550CALL0 076.57FALSE00
2026-07-17350PUT0 0114.6FALSE00
2026-07-17400PUT0 0146.82FALSE00
2026-07-17450PUT0 0130.02FALSE00
2026-07-17500PUT0 0115.09FALSE00
2026-07-17550PUT0 19101.61FALSE00
2026-07-17600PUT0 389.26FALSE00
2026-07-17650PUT0 077.81FALSE00
2026-07-17700PUT0 679.21FALSE00
2026-07-17750PUT0 077.07FALSE00
2026-07-17800PUT0 5074.58FALSE00
2026-07-17850PUT0 073.86FALSE00
2026-07-17900PUT0 072.63FALSE00
2026-07-17950PUT0 072.32FALSE00
2026-07-171000PUT0 070TRUE00
2026-07-171050PUT0 071.27TRUE00
2026-07-171100PUT0 071.79TRUE00
2026-07-171150PUT0 071.94TRUE00
2026-07-171200PUT0 072.14TRUE00
2026-07-171250PUT0 072.21TRUE00
2026-07-171300PUT0 073.27TRUE00
2026-07-171350PUT0 072.85TRUE00
2026-07-171400PUT0 073.78TRUE00
2026-07-171450PUT0 074.09TRUE00
2026-07-171500PUT0 075.45TRUE00
2026-07-171550PUT0 075.35TRUE00
2026-10-16450CALL0 092.16TRUE00
2026-10-16500CALL0 090.17TRUE00
2026-10-16550CALL0 089.37TRUE00
2026-10-16600CALL0 087.56TRUE00
2026-10-16650CALL0 085.99TRUE00
2026-10-16700CALL0 085.39TRUE00
2026-10-16750CALL0 083.81TRUE00
2026-10-16800CALL0 082.85TRUE00
2026-10-16850CALL0 080.7TRUE00
2026-10-16900CALL0 080.58TRUE00
2026-10-16950CALL0 079.74TRUE00
2026-10-161000CALL0 079.42FALSE00
2026-10-161050CALL0 078.49FALSE00
2026-10-161100CALL0 078.86FALSE00
2026-10-161150CALL0 078.71FALSE00
2026-10-161200CALL0 079.56FALSE00
2026-10-161250CALL0 078.86FALSE00
2026-10-161300CALL0 079.25FALSE00
2026-10-161350CALL0 079.27FALSE00
2026-10-161400CALL0 081.11FALSE00
2026-10-161450CALL0 080.29FALSE00
2026-10-161500CALL0 081.59FALSE00
2026-10-161550CALL0 080.15FALSE00
2026-10-16450PUT0 093.05FALSE00
2026-10-16500PUT0 392.39FALSE00
2026-10-16550PUT0 389.94FALSE00
2026-10-16600PUT0 086.77FALSE00
2026-10-16650PUT0 084.89FALSE00
2026-10-16700PUT0 082.97FALSE00
2026-10-16750PUT0 082.71FALSE00
2026-10-16800PUT0 081.48FALSE00
2026-10-16850PUT0 079.93FALSE00
2026-10-16900PUT0 078.91FALSE00
2026-10-16950PUT0 079.55FALSE00
2026-10-161000PUT0 079.09TRUE00
2026-10-161050PUT0 078.94TRUE00
2026-10-161100PUT0 078.95TRUE00
2026-10-161150PUT0 077.5TRUE00
2026-10-161200PUT0 077.78TRUE00
2026-10-161250PUT0 078.72TRUE00
2026-10-161300PUT0 079.26TRUE00
2026-10-161350PUT0 079.43TRUE00
2026-10-161400PUT0 079.22TRUE00
2026-10-161450PUT0 178.84TRUE00
2026-10-161500PUT0 079.82TRUE00
2026-10-161550PUT0 179.46TRUE00
2026-12-18350CALL0 086.67TRUE00
2026-12-18400CALL0 087.26TRUE00
2026-12-18450CALL0 084.11TRUE00
2026-12-18500CALL0 081.85TRUE00
2026-12-18550CALL0 180.44TRUE00
2026-12-18600CALL0 579.24TRUE00
2026-12-18650CALL0 077.43TRUE00
2026-12-18700CALL0 677.04TRUE00
2026-12-18750CALL0 10276.02TRUE00
2026-12-18800CALL0 5174.35TRUE00
2026-12-18850CALL0 072.89TRUE00
2026-12-18900CALL0 13472.83TRUE00
2026-12-18950CALL0 8372.35TRUE00
2026-12-181000CALL0 772FALSE00
2026-12-181050CALL0 1371.81FALSE00
2026-12-181100CALL0 571.48FALSE00
2026-12-181150CALL0 371.69FALSE00
2026-12-181200CALL0 771.5FALSE00
2026-12-181250CALL0 071.6FALSE00
2026-12-181300CALL0 072FALSE00
2026-12-181350CALL0 2072.11FALSE00
2026-12-181400CALL0 072.6FALSE00
2026-12-181450CALL0 072.67FALSE00
2026-12-181509.2CALL0 3077.11FALSE00
2026-12-181550CALL0 172.43FALSE00
2026-12-18350PUT0 0102.85FALSE00
2026-12-18400PUT0 091.05FALSE00
2026-12-18450PUT0 280.76FALSE00
2026-12-18500PUT0 281.41FALSE00
2026-12-18550PUT0 081.47FALSE00
2026-12-18600PUT0 2577.77FALSE00
2026-12-18650PUT0 077.19FALSE00
2026-12-18700PUT0 077.07FALSE00
2026-12-18750PUT0 074.39FALSE00
2026-12-18800PUT0 3178.08FALSE00
2026-12-18850PUT0 076.03FALSE00
2026-12-18900PUT0 072.46FALSE00
2026-12-18950PUT0 272.62FALSE00
2026-12-181000PUT0 071.21TRUE00
2026-12-181050PUT0 071.93TRUE00
2026-12-181100PUT0 071.19TRUE00
2026-12-181150PUT0 071.29TRUE00
2026-12-181200PUT0 070.97TRUE00
2026-12-181250PUT0 071.57TRUE00
2026-12-181300PUT0 071.49TRUE00
2026-12-181350PUT0 071.74TRUE00
2026-12-181400PUT0 072.37TRUE00
2026-12-181450PUT0 073.08TRUE00
2026-12-181500PUT0 072.49TRUE00
2026-12-181550PUT0 073.46TRUE00
2027-01-15450CALL0 080.16TRUE00
2027-01-15500CALL0 078.27TRUE00
2027-01-15550CALL0 077.11TRUE00
2027-01-15600CALL0 076.11TRUE00
2027-01-15650CALL0 075.23TRUE00
2027-01-15700CALL0 473.59TRUE00
2027-01-15750CALL0 171.98TRUE00
2027-01-15800CALL0 771.33TRUE00
2027-01-15850CALL0 070.59TRUE00
2027-01-15900CALL0 069.65TRUE00
2027-01-15950CALL0 2069.01TRUE00
2027-01-151000CALL0 468.68FALSE00
2027-01-151050CALL0 1069.43FALSE00
2027-01-151100CALL0 168.2FALSE00
2027-01-151150CALL0 068.86FALSE00
2027-01-151200CALL0 068.39FALSE00
2027-01-151250CALL0 068.34FALSE00
2027-01-1513014CALL0 268.74FALSE00
2027-01-151350CALL0 168.86FALSE00
2027-01-151400CALL0 068.87FALSE00
2027-01-151450CALL0 069.75FALSE00
2027-01-151500CALL0 169.13FALSE00
2027-01-151550CALL0 169.92FALSE00
2027-01-15450PUT0 081.49FALSE00
2027-01-15500PUT0 078.48FALSE00
2027-01-15550PUT0 077.44FALSE00
2027-01-15600PUT0 074.5FALSE00
2027-01-15650PUT0 075.1FALSE00
2027-01-15700PUT0 073.11FALSE00
2027-01-15750PUT0 072.59FALSE00
2027-01-15800PUT0 571.38FALSE00
2027-01-15850PUT0 069.79FALSE00
2027-01-159017.5PUT0 10169.37FALSE00
2027-01-15950PUT0 369.54FALSE00
2027-01-151000PUT0 069.63TRUE00
2027-01-151050PUT0 068.92TRUE00
2027-01-151100PUT0 069.16TRUE00
2027-01-151150PUT0 069.28TRUE00
2027-01-151200PUT0 069.01TRUE00
2027-01-151250PUT0 069.31TRUE00
2027-01-151300PUT0 069.9TRUE00
2027-01-151350PUT0 069.24TRUE00
2027-01-151400PUT0 070.2TRUE00
2027-01-151450PUT0 069.95TRUE00
2027-01-151500PUT0 070.11TRUE00
2027-01-151550PUT0 070.18TRUE00

Latest MIRM Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST4$20.27
Jun 13, 2022 7:59 PM EST34$20.26
Jun 13, 2022 7:59 PM EST50$20.26
Jun 13, 2022 7:59 PM EST50$20.26
Jun 13, 2022 7:59 PM EST100$20.24

Mirum Pharmaceuticals, Inc (MIRM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2019-06-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019010501/0000000000-19-010501-index.htm
2019-07-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019010921/0000000000-19-010921-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000019016859/0000000000-19-016859-index.htm
2020-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1759425/000000000020007237/0000000000-20-007237-index.htm
2019-12-27DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1759425/000095012319012069/0000950123-19-012069-index.htm
2019-07-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000107261319000249/0001072613-19-000249-index.htm
2019-12-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000117266119002410/0001172661-19-002410-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000117266120000737/0001172661-20-000737-index.htm
2019-06-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519184371/0001193125-19-184371-index.htm
2019-07-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312519189959/0001193125-19-189959-index.htm
2019-07-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519189965/0001193125-19-189965-index.htm
2019-07-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312519193277/0001193125-19-193277-index.htm
2019-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519193289/0001193125-19-193289-index.htm
2019-07-158-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1759425/000119312519194022/0001193125-19-194022-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519194112/0001193125-19-194112-index.htm
2019-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312519194115/0001193125-19-194115-index.htm
2019-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759425/000119312519196500/0001193125-19-196500-index.htm
2019-07-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519200063/0001193125-19-200063-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519202499/0001193125-19-202499-index.htm
2019-07-26SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519204056/0001193125-19-204056-index.htm
2019-08-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312519210092/0001193125-19-210092-index.htm
2019-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519232419/0001193125-19-232419-index.htm
2019-08-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759425/000119312519232544/0001193125-19-232544-index.htm
2019-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312519324949/0001193125-19-324949-index.htm
2020-01-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000119312520002291/0001193125-20-002291-index.htm
2020-01-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312520002347/0001193125-20-002347-index.htm
2020-01-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1759425/000119312520002352/0001193125-20-002352-index.htm
2020-01-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759425/000119312520004784/0001193125-20-004784-index.htm
2020-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000119312520007165/0001193125-20-007165-index.htm
2020-01-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312520009903/0001193125-20-009903-index.htm
2020-04-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759425/000119312520126318/0001193125-20-126318-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000651/0001193805-19-000651-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000119380519000662/0001193805-19-000662-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000119380520000192/0001193805-20-000192-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042429/0001209191-19-042429-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042433/0001209191-19-042433-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042435/0001209191-19-042435-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042437/0001209191-19-042437-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042439/0001209191-19-042439-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042441/0001209191-19-042441-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042442/0001209191-19-042442-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042445/0001209191-19-042445-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042446/0001209191-19-042446-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042447/0001209191-19-042447-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042448/0001209191-19-042448-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042449/0001209191-19-042449-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042451/0001209191-19-042451-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042453/0001209191-19-042453-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042454/0001209191-19-042454-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042455/0001209191-19-042455-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042456/0001209191-19-042456-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042457/0001209191-19-042457-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042458/0001209191-19-042458-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042460/0001209191-19-042460-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042470/0001209191-19-042470-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042476/0001209191-19-042476-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042479/0001209191-19-042479-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042482/0001209191-19-042482-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042486/0001209191-19-042486-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042489/0001209191-19-042489-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042657/0001209191-19-042657-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043021/0001209191-19-043021-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2019-10-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119054233/0001209191-19-054233-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919119054240/0001209191-19-054240-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120000307/0001209191-20-000307-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003335/0001209191-20-003335-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003338/0001209191-20-003338-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003342/0001209191-20-003342-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003345/0001209191-20-003345-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120003348/0001209191-20-003348-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2020-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120026416/0001209191-20-026416-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120026418/0001209191-20-026418-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036572/0001209191-20-036572-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036581/0001209191-20-036581-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036587/0001209191-20-036587-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036594/0001209191-20-036594-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036597/0001209191-20-036597-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120036618/0001209191-20-036618-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-07-16CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1759425/000135445719000353/0001354457-19-000353-index.htm
2019-09-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759425/000139506419000029/0001395064-19-000029-index.htm
2019-08-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459019033345/0001564590-19-033345-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459019040998/0001564590-19-040998-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459019041030/0001564590-19-041030-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020010454/0001564590-20-010454-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1759425/000156459020010471/0001564590-20-010471-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1759425/000156459020019713/0001564590-20-019713-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1759425/000156459020019725/0001564590-20-019725-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020022831/0001564590-20-022831-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459020022856/0001564590-20-022856-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759425/000156459020023010/0001564590-20-023010-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2020-08-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000156459020035305/0001564590-20-035305-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759425/000156459020037717/0001564590-20-037717-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759425/000156459020037771/0001564590-20-037771-index.htm
2020-08-10S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1759425/000156459020038927/0001564590-20-038927-index.htm
2019-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999519001627/9999999995-19-001627-index.htm
2020-01-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999520000041/9999999995-20-000041-index.htm
2020-08-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759425/999999999520002122/9999999995-20-002122-index.htm
2019-07-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1759425/999999999719006082/9999999997-19-006082-index.htm

Mirum Pharmaceuticals, Inc (MIRM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirum Pharmaceuticals, Inc (MIRM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 909%
Institutional Ownership: 7089%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-10Laura BregeDirectorBuy10,000.0011.22112,200.0010,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-06Pamela VigChief Scientific OfficerBuy1,600.0010.9617,539.201,600.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-06Pamela VigChief Scientific OfficerBuy12.0011.88142.561,612.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-07-22James E Flynn10% Share HolderBuy166,000.0015.002,490,000.00166,000.00https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06Laurent FischerDirectorBuy1,720.0010.7118,429.281,720.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-07-22James E Flynn10% Share HolderBuy166,000.0015.002,490,000.001,724,456.00https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06Ian ClementsSVP Finance & CommunicationsBuy1,801.0011.0719,937.071,801.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22Niall O'DonnellDirectorBuy300,000.0015.004,500,000.001,921,118.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-09-06Christopher PeetzPresident and CEOBuy4,750.0010.9151,805.88192,250.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09Christopher PeetzPresident and CEOBuy2,000.0010.9021,800.00194,250.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09Christopher PeetzPresident and CEOBuy2,320.0011.3526,332.00196,570.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-07-22Holdings A/S Novo10% Share HolderBuy575,000.0015.008,625,000.002,445,147.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2020-10-30Edwin Jonathan TuckerChief Medical OfficerBuy25,000.007.70192,500.0031,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-09-09Laurent FischerDirectorBuy1,670.0010.5417,601.803,390.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2020-03-19Edwin Jonathan TuckerChief Medical OfficerBuy2,000.009.9119,818.003,500.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-07-22Frazier Life Sciences IX, L.P.10% Share HolderBuy450,000.0015.006,750,000.003,566,912.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-22Patrick J HeronDirectorBuy450,000.0015.006,750,000.003,566,912.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-09-09Laurent FischerDirectorBuy300.0011.303,390.003,690.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-06Ian ClementsSVP Finance & CommunicationsBuy2,199.0011.8726,102.134,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22Ali Behbahani10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-22Anthony A. Jr. Florence10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-22Carmen Chang10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-22DAVID M MOTT10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-22FOREST BASKETT10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-22JOSHUA MAKOWER10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-22Mohamad Makhzoumi10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-22New Enterprise Associates 16, L.P.10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-22Paul Edward Walker10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-07-22PETER J BARRIS10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-22Peter W. Sonsini10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-22SCOTT D SANDELL10% Share HolderBuy450,000.0015.006,750,000.004,186,243.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-09-10Laurent FischerDirectorBuy960.0010.299,881.474,650.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-16Laurent FischerDirectorBuy452.009.474,280.445,102.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2020-03-20Edwin Jonathan TuckerChief Medical OfficerBuy2,500.0011.9029,740.006,000.00https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-09-17Laurent FischerDirectorBuy1,648.009.3715,435.176,750.00https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm